Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Cell Bank is a leading biotechnology entity based in Shenzhen, China, specializing in the storage, processing, and research of human cells. Established with government support and often operated in conjunction with Beike Biotechnology, it serves as a critical infrastructure for the regional life sciences industry. The company provides high-standard cryopreservation services for various cell types, including mesenchymal stem cells, immune cells, and cord blood cells. Beyond storage, Shenzhen Cell Bank is involved in the development of cell-based therapies and provides standardized cell products for clinical research and regenerative medicine applications. Its facilities are designed to meet international GMP standards, ensuring the quality and safety of biological materials for long-term therapeutic use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Cell Bank.